Results 1 - 10 of 40

< 1 2 3 4 >

• [DOI: 10.1021/jm301085w]
  
• Hasskarl J. Sorafenib: targeting multiple tyrosine kinases in cancer., Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

  [DOI: 10.1007/978-3-642-54490-3_8]
  
• Rational Therapy for Renal Cell Carcinoma Based on its Genetic Targets, Impact of Genetic Targets on Cancer Therapy

  [DOI: 10.1007/978-1-4614-6176-0_13]
  
• Targeting the VEGF Pathway in Renal Cell Carcinoma, Renal Cell Carcinoma

  [DOI: 10.1007/978-1-4614-2400-0_6]
  
• Angiogenesis Inhibitor Therapy in Renal Cell Cancer, Kidney Cancer

  [DOI: 10.1007/978-3-319-17903-2_17]
  
• Third-Generation TKIs (Axitinib, Tivozanib) in RCC: Enhanced Efficacy and Diminished Toxicity?, Renal Cell Carcinoma

  [DOI: 10.1007/978-1-4939-1622-1_10]
  
• Side Effects of Targeted Therapy, Renal Cell Carcinoma

  [DOI: 10.1007/978-1-4939-1622-1_18]
  
• First-Generation Tyrosine Kinase Inhibitors: Clinical Results, Renal Cell Carcinoma

  [DOI: 10.1007/978-1-4939-1622-1_8]
  
• Angiogenesis Inhibitor Therapy in Renal Cell Cancer, Kidney Cancer

  [DOI: 10.1007/978-3-642-21858-3_13]
  
• Forthcoming Drugs for Metastatic Renal Cell Carcinoma Therapy, Renal Cell Carcinoma

  [DOI: 10.1007/978-4-431-55531-5_14]